Sarepta Therapeutics (SRPT)

P/S ratio as of March 2025 (TTM): 3.73

According to Sarepta Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.64. At the end of 2024 the company had a P/S ratio of 6.10.

P/S ratio history for Sarepta Therapeutics from 2001 to 2024

PS ratio at the end of each year

Year	P/S ratio	Change
2024	6.10	-15.9%
2023	7.26	-40.49%
2022	12.2	9.13%
2021	11.2	-55.15%
2020	24.9	-2.22%
2019	25.5	-1.12%
2018	25.8	10.75%
2017	23.3	-91.58%
2016	276	-80.34%
2015	> 1000	2193.16%
2014	61.3	13.28%
2013	54.1	146.82%
2012	21.9	918.16%
2011	2.15	-73.42%
2010	8.10	-11.73%
2009	9.17	316.41%
2008	2.20	-73.37%
2007	8.27	-99.44%
2006	> 1000	3874.02%
2005	36.9	-81.29%
2004	197	36.42%
2003	145	-8.87%
2002	159	-55.81%
2001	359

P/S ratio for similar companies or competitors

Company	P/S ratio	P/S ratio differencediff.	Country
Gilead Sciences GILD	4.65	24.59%	🇺🇸 USA
Novavax NVAX	1.78	-52.41%	🇺🇸 USA
Avidity Biosciences RNA	352	9,322.80%	🇺🇸 USA
BioCryst Pharmaceuticals BCRX	3.65	-2.07%	🇺🇸 USA
Alnylam Pharmaceuticals ALNY	16.2	333.76%	🇺🇸 USA
PTC Therapeutics PTCT	5.50	47.43%	🇺🇸 USA
Insmed INSM	38.8	940.04%	🇺🇸 USA

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions

P/S ratio for Sarepta Therapeutics (SRPT)

P/S ratio as of March 2025 (TTM): 3.73